Cargando…
SOX2 Is a Potential Novel Marker of Undifferentiated Thyroid Carcinomas
Background Thyroid cancer is a very common endocrine malignancy. Cancer stem cells are attributable to initiation, progression, and treatment failure in thyroid carcinoma. In the current study, immunostaining of SRY-box 2 (SOX2) in thyroid carcinoma is investigated. Material and methods Tissue micro...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805510/ https://www.ncbi.nlm.nih.gov/pubmed/33489519 http://dx.doi.org/10.7759/cureus.12102 |